yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35011473-79A7EC53-DCFD-48F4-BBCF-BBA908C8DEC2
Q35011473-79A7EC53-DCFD-48F4-BBCF-BBA908C8DEC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35011473-79A7EC53-DCFD-48F4-BBCF-BBA908C8DEC2
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP.
P2860
Q35011473-79A7EC53-DCFD-48F4-BBCF-BBA908C8DEC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35011473-79A7EC53-DCFD-48F4-BBCF-BBA908C8DEC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a46aa361b036b834706b2cf023ce53a5aa7cb0a
P2860
Isoquinolin-1-one inhibitors of the MDM2-p53 interaction.